6 results
10-K
2020 FY
EX-10.17
AUPH
Aurinia Pharmaceuticals Inc
24 Feb 21
Annual report
4:09pm
others in the organization.
Demonstrated ability to work effectively with colleagues, government, stakeholder leadership, and the public.
Certain
40FR12B/A
EX-99.15
AUPH
Aurinia Pharmaceuticals Inc
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
ensures that this significant market opportunity is well protected and provides a powerful platform to create true stakeholder value.
2012 CORPORATE
40FR12B/A
EX-99.26
AUPH
Aurinia Pharmaceuticals Inc
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
to create true stakeholder value.
THE COMPANY’S DRUG DEVELOPMENT PROGRAMS
Voclosporin, Isotechnika’s lead drug, belongs to a class of drugs called
40FR12B/A
EX-99.24
AUPH
Aurinia Pharmaceuticals Inc
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
ensures that this significant market opportunity is well protected and provides a powerful platform to create true stakeholder value.
2012 CORPORATE
40FR12B/A
EX-99.25
AUPH
Aurinia Pharmaceuticals Inc
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
to create true stakeholder value.
Financing Activities
Subsequent to March 31, 2013, the Company entered into two agreements with Canaccord Genuity
40FR12B/A
EX-99.44
55eyp3euv51r 6bm
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
- Prev
- 1
- Next